Bio

Patrick is a Founding Partner at Stanley Capital. Since founding Stanley, he co-led the investments into Noden Pharma, Qinecsa and Laboratoire XO. Prior to SCP, Patrick was a hybrid between a private equity and a special situations investor at both Centerbridge Partners and Monarch Alternative Capital. He started his career as an investment banker at JP Morgan. Over the course of his career, he has taken on significant board responsibilities and executed successful platform buy and builds in the Healthcare and Resource Efficiency sectors. Patrick holds a Masters in Mathematics summa cum laude from the Technical University Munich.